Prescription drug · NDA
Vasostrict (vasopressin) NDC 71872-7264
Vasopressin, Unspecified 20 [USP'U]/mL · Injection · Intravenous · Medical Purchasing Solutions, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71872-7264-1 | 71872726401 | 1 VIAL in 1 BAG (71872-7264-1) / 1 mL in 1 VIALMarketed from Aug 19, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Vasostrict
- Generic name (nonproprietary)
- vasopressin
- Active ingredients
- Vasopressin, Unspecified — 20 [USP'U]/mL
- Dosage form
- Injection
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 204485
- Marketing start
- Listing expires
- Identifiers
- Product ID 71872-7264_facc32bf-5a56-24d8-e053-6394a90a080fSPL ID facc32bf-5a56-24d8-e053-6394a90a080fSPL set ID d162d386-105d-e916-e053-2995a90a350cRxCUI 2103182, 2103184UNII Y87Y826H08
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N471872726401followed by a unit qualifier and the quantityPackage 71872-7264-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Vasostrict ® is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. Vasostrict ® is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 204485
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Vasostrictvasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | Par Health USA, LLC | 42023-164 |
| Vasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1314 |
| Vasostrictvasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | Par Health USA, LLC | 42023-164 |
| Vasostrictvasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | Par Health USA, LLC | 42023-190 |
| Vasostrictvasopressin | Vasopressin, Unspecified .4 [USP'U]/mL | InjectionIntravenous | Par Health USA, LLC | 42023-219 |
| Vasostrictvasopressin | Vasopressin, Unspecified .2 [USP'U]/mL | InjectionIntravenous | Par Health USA, LLC | 42023-237 |
| Vasostrictvasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | Medical Purchasin Solutions, LLC | 71872-7014 |